Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal ... : vimarsana.com

As the first-ever U.S. Food and Drug Administration (FDA) approved over-the-counter (OTC) naloxone in 2023, Emergent is working to expand access with NARCAN® Nasal Spray and build on its longstanding

Related Keywords

United States , Canada , Americans , Richards Lindahl , Paul Williams , Assal Hellmer , Joseph Papa , Instagram , National Safety Council , Drug Administration , Health Spending Account , Biden Administration , Emergent Biosolutions Inc , Exchange Commission , Centers For Disease , Us Centers For Disease , Linkedin , Nasal Spray , White House Challenge , Save Lives , Disease Control , Suggested Retail Price , Flexible Saving Account , Apple Podcasts , Private Securities Litigation Reform Act , Vice President , Drug Overdose Deaths , Understanding Drug Overdoses , Region ,